Anzeige
Mehr »
Login
Mittwoch, 08.02.2023 Börsentäglich über 12.000 News von 679 internationalen Medien
Noch einmal große Einstiegschance!? - Warum genau jetzt aktiv werden…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12B8E ISIN: IE00BQPVQZ61 Ticker-Symbol: HPR 
Tradegate
06.02.23
17:44 Uhr
102,82 Euro
+0,44
+0,43 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
HORIZON THERAPEUTICS PLC Chart 1 Jahr
5-Tage-Chart
HORIZON THERAPEUTICS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
102,06102,6007.02.
100,84103,9007.02.
PR Newswire
241 Leser
Artikel bewerten:
(1)

Pentwater Capital Management LP - Form 8.3 - Horizon Therapeutics Plc

Pentwater Capital Management LP - Form 8.3 - Horizon Therapeutics Plc

PR Newswire

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

(a) Full name of discloserPentwater Capital Management LP
(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a)
The naming of nominee or vehicle companies isinsufficient. For a trust, the trustee(s), settlor andbeneficiaries must be named.
(c) Name of offeror/offeree in relation to whoserelevant securities this form relates
Use a separate form for each offeror/offeree
Horizon Therapeutics Plc
(d) If an exempt fund manager connected with anofferor/offeree, state this and specify identityof offeror/offeree (Note 1)
(e) Date position held/dealing undertaken
For an opening position disclosure, state thelatest practicable date prior to the disclosure
24 January 2023
(f) In addition to the company in 1(c) above, is thediscloser also making disclosures in respectof any other party to the offer?
If it is a cash offer or possible cash offer, state"N/A"
NO
If YES, specifywhich:

2. INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security
(Note 3)
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled4,060,0001.77%
(2) Cash-settled derivatives
(3) Stock-settled derivatives(including options) andagreements to purchase/sell9,4660.00%
Total4,069,4661.77%

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant
security
Purchase/saleNumber of
securities
Price per unit
(Note 5)
$0.0001 Ordinary SharesPurchase10,000113.0095
$0.0001 Ordinary SharesPurchase100,000112.9998

PurAp29

(b) Cash-settled derivative transactions

Class of
relevant
security
Product
description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position,increasing/ reducing a long/ short position
Number of
reference
securities
(Note 6)
Price
per unit
(Note 5)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of
relevant
security
Product
descriptione.g. call
option
Writing,purchasing,selling,varying
etc.
Number
of
securities
to which
option
relates
(Note 6)
Exercise
price per

unit
Type
e.g.
American,
European
etc.
Expiry
date
Option
money
paid/

receivedper unit

(ii) Exercise

Class of
relevant
security
Product
description
e.g. call
option
Exercising/
exercised
against
Number of
securities
Exercise
price per
unit
(Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 3)

Class of
relevant
security
Nature of dealing
e.g. subscription,
conversion, exercise
DetailsPrice per unit (if
applicable)
(Note 5)

Ap30

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreementor understanding, formal or informal, relating to relevant securitieswhich may be an inducement to deal or refrain from dealingentered into by the person making the disclosure and any party tothe offer or any person acting in concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. Ifthere are no such agreements, arrangements or understandings, state"none"
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understandingbetween the person disclosing and any other person relatingto the voting rights of any relevant securities under any optionreferred to on this form or relating to the voting rights or futureacquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, thisshould be stated.
None

(c) Attachments

Is a Supplemental Form 8 attached?NO

Date of disclosure25/01/2023
Contact nameHooman Tavakolian
Telephone number212.739.6128

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap31

NOTES ON FORM 8.3

1. See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

2. See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

4. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

6.See Rule 2.5(d) of Part A of the Rules.

7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Comeback Aktien - Fünf Top-Werte für Ihr Depot
Jetzt im kostenlosen Report: Schwierige Zeiten an der Börse brauchen starke Aktien. Am besten solche, die auch noch günstig zu haben sind. Börsenprofi Lars Wißler hat fünf Top-Werte für Sie herausgesucht.
© 2023 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.